DOCSLIB.ORG

Summary of Notifiable Diseases — United States, 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Summary of Notifiable Diseases — United States, 2010 Morbidity and Mortality Weekly Report Weekly / Vol. 59 / No. 53 June 1, 2012 Summary of Notifiable Diseases — United States, 2010 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report CONTENTS Preface .......................................................................................................................2 TABLE 5. Reported cases and incidence* of notifiable diseases,† by Background .............................................................................................................2 race — United States, 2010 .......................................................................... 43 Infectious Diseases Designated as Notifiable at the National Level TABLE 6. Reported cases and incidence* of notifiable diseases,† by during 2010* .........................................................................................................3 ethnicity — United States, 2010 ................................................................. 45 Data Sources ...........................................................................................................4 PART 2: Graphs and Maps for Selected Notifiable Diseases Interpreting Data ...................................................................................................4 in the United States, 2010 ............................................................................. 47 Transition in NNDSS Data Collection and Reporting ................................5 PART 3: Historical Summaries of Notifiable Diseases Methodology for Identifying which Nationally Notifiable Infectious in the United States, 1979–2010................................................................. 91 Diseases are Reportable ...................................................................................6 TABLE 7. Reported incidence* of notifiable diseases — United States, Revised International Health Regulations ....................................................6 2000–2010 .......................................................................................................... 92 Highlights for 2010 ............................................................................................ 11 TABLE 8. Reported cases of notifiable diseases — United States, PART 1: Summaries of Notifiable Diseases in the United States, 2003–2010 .......................................................................................................... 95 2010 ...................................................................................................................... 23 TABLE 9. Reported cases of notifiable diseases — United States, TABLE 1. Reported cases of notifiable diseases,* by month — United 1995–2002 .......................................................................................................... 98 States, 2010 ........................................................................................................ 24 TABLE 10. Reported cases of notifiable diseases* — United States, TABLE 2. Reported cases of notifiable diseases,* by geographic 1987–1994 ........................................................................................................100 division and area — United States, 2010 ................................................ 26 TABLE 11. Reported cases of notifiable diseases* — United States, TABLE 3. Reported cases and incidence* of notifiable diseases,† by 1979–1986 ........................................................................................................102 age group — United States, 2010 .............................................................. 39 TABLE 12. Number of deaths from selected nationally notifiable TABLE 4. Reported cases and incidence* of notifiable diseases,† by infectious diseases — United States, 2002–2008 ...............................103 sex — United States, 2010 ............................................................................ 41 Selected Reading for 2010 ............................................................................105 The MMWR series of publications is published by the Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30333. Suggested Citation: Centers for Disease Control and Prevention. [Summary of Notifiable Diseases, 2010]. Published June 1, 2012 for MMWR 2010;59(No. 53):[inclusive page numbers]. Centers for Disease Control and Prevention Thomas R. Frieden, MD, MPH, Director Harold W. Jaffe, MD, MA, Associate Director for Science James W. Stephens, PhD, Director, Office of Science Quality Stephen B. Thacker, MD, MSc, Deputy Director for Surveillance, Epidemiology, and Laboratory Services Stephanie Zaza, MD, MPH, Director, Epidemiology and Analysis Program Office MMWR Editorial and Production Staff Ronald L. Moolenaar, MD, MPH, Editor, MMWR Series Martha F. Boyd, Lead Visual Information Specialist John S. Moran, MD, MPH, Deputy Editor, MMWR Series Maureen A. Leahy, Julia C. Martinroe, Christine G. Casey, MD, Deputy Editor, MMWR Series Stephen R. Spriggs, Terraye M. Starr Teresa F. Rutledge, Managing Editor, MMWR Series Visual Information Specialists David C. Johnson, Lead Technical Writer-Editor Quang M. Doan, MBA, Phyllis H. King Suzanne M. Hewitt, MPA, Project Editor Information Technology Specialists MMWR Editorial Board William L. Roper, MD, MPH, Chapel Hill, NC, Chairman Matthew L. Boulton, MD, MPH, Ann Arbor, MI Dennis G. Maki, MD, Madison, WI Virginia A. Caine, MD, Indianapolis, IN Patricia Quinlisk, MD, MPH, Des Moines, IA Jonathan E. Fielding, MD, MPH, MBA, Los Angeles, CA Patrick L. Remington, MD, MPH, Madison, WI David W. Fleming, MD, Seattle, WA John V. Rullan, MD, MPH, San Juan, PR William E. Halperin, MD, DrPH, MPH, Newark, NJ William Schaffner, MD, Nashville, TN King K. Holmes, MD, PhD, Seattle, WA Dixie E. Snider, MD, MPH, Atlanta, GA Deborah Holtzman, PhD, Atlanta, GA John W. Ward, MD, Atlanta, GA Timothy F. Jones, MD, Nashville, TN Morbidity and Mortality Weekly Report Summary of Notifiable Diseases — United States, 2010 Prepared by Deborah A. Adams, Coordinator, Summary of Notifiable Diseases1 Kathleen M. Gallagher, D.Sc, MPH, Division Director1 Ruth Ann Jajosky, DMD, MPH1 Jennifer Ward, MS1 Pearl Sharp1 Willie J. Anderson1 John P. Abellera, MPH1 Aaron E. Aranas, MPH, MBA1 Michelle Mayes1 Michael S. Wodajo1 Diana H. Onweh1 Meeyoung Park2 1Division of Notifiable Diseases and Healthcare Information (proposed), the Office of Surveillance, Epidemiology, and Laboratory Services, CDC 2McKing Consulting Corporation MMWR / June 1, 2012 / Vol. 59 / No. 53 1 Morbidity and Mortality Weekly Report Preface Background The Summary of Notifiable Diseases United States, 2010 con- The infectious diseases designated as notifiable at the national tains the official statistics, in tabular and graphic form, for the level during 2010 are listed in this section. A notifiable disease is reported occurrence of nationally notifiable infectious diseases one for which regular, frequent, and timely information regard- in the United States for 2010. Unless otherwise noted, the data ing individual cases is considered necessary for the prevention are final totals for 2010, reported as of June 30, 2011. These and control of the disease. A brief history of the reporting of statistics are collected and compiled from reports sent by state nationally notifiable infectious diseases in the United States is health departments and territories to the National Notifiable available at http://www.cdc.gov/osels/ph_surveillance/nndss/ Diseases Surveillance System (NNDSS), which is operated by nndsshis.htm. In 1961, CDC assumed responsibility for the col- CDC in collaboration with the Council of State and Territorial lection and publication of data on nationally notifiable diseases. Epidemiologists (CSTE). The Summary is available at http:// NNDSS is neither a single surveillance system nor a method of www.cdc.gov/mmwr/mmwr_su/mmwr_nd/. This site also reporting. Certain NNDSS data are reported to CDC through includes Summary publications from previous years. separate surveillance information systems and through different The Highlights section presents noteworthy epidemiologic reporting mechanisms; however, these data are aggregated and and prevention information from 2010 for selected diseases and compiled for publication purposes. additional information to aid in the interpretation of surveil- Notifiable disease reporting at the local level protects the lance and disease-trend data. Part 1 contains tables illustrating public’s health by ensuring the proper identification and incidence data for the nationally notifiable infectious diseases follow-up of cases. Public health workers ensure that persons reported during 2010.* The tables provide the number of cases who are already ill receive appropriate treatment; trace contacts reported to CDC for 2010 and the distribution of cases by who need vaccines, treatment, quarantine, or education; inves- month, geographic location, and the patients’ demographic tigate and halt outbreaks; eliminate environmental hazards; characteristics (age, sex, race, and ethnicity). Part 2 contains and close premises where spread has occurred. Surveillance of graphs and maps that depict summary data for certain notifi- notifiable conditions helps public health authorities to moni- able infectious diseases described in tabular form in Part 1. tor the effect of notifiable conditions,
Load more

Recommended publications
  • Official Nh Dhhs Health Alert
    THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network [email protected] May 18, 2018, 1300 EDT (1:00 PM EDT) NH-HAN 20180518 Tickborne Diseases in New Hampshire Key Points and Recommendations: 1. Blacklegged ticks transmit at least five different infections in New Hampshire (NH): Lyme disease, Anaplasma, Babesia, Powassan virus, and Borrelia miyamotoi. 2. NH has one of the highest rates of Lyme disease in the nation, and 50-60% of blacklegged ticks sampled from across NH have been found to be infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. 3. NH has experienced a significant increase in human cases of anaplasmosis, with cases more than doubling from 2016 to 2017. The reason for the increase is unknown at this time. 4. The number of new cases of babesiosis also increased in 2017; because Babesia can be transmitted through blood transfusions in addition to tick bites, providers should ask patients with suspected babesiosis whether they have donated blood or received a blood transfusion. 5. Powassan is a newer tickborne disease which has been identified in three NH residents during past seasons in 2013, 2016 and 2017. While uncommon, Powassan can cause a debilitating neurological illness, so providers should maintain an index of suspicion for patients presenting with an unexplained meningoencephalitis. 6. Borrelia miyamotoi infection usually presents with a nonspecific febrile illness similar to other tickborne diseases like anaplasmosis, and has recently been identified in one NH resident. Tests for Lyme disease do not reliably detect Borrelia miyamotoi, so providers should consider specific testing for Borrelia miyamotoi (see Attachment 1) and other pathogens if testing for Lyme disease is negative but a tickborne disease is still suspected.
    [Show full text]
  • Shigella Infection - Factsheet
    Shigella Infection - Factsheet What is Shigellosis? How common is it? Shigellosis is an infectious disease caused by a group of bacteria (germs) called Shigella. It’s also known as bacillary dysentery. There are four main types of Shigella germ but Shigella sonnei is by far the commonest cause of this illness in the UK. Most cases of the other types are usually brought in from abroad. How is Shigellosis caught? Shigella is not known to be found in animals so it always passes from one infected person to the next, though the route may be indirect. Here are some possible ways in which you can get infected: • Shigella germs are present in the stools of infected persons while they are ill and for a week or two afterwards. Most Shigella infections are the result of germs passing from stools or soiled fingers of one person to the mouth of another person. This happens when basic hygiene and hand washing habits are inadequate, such as in young toddlers who are not yet fully toilet trained. Family members and playmates of such children are at high risk of becoming infected. • Shigellosis can be acquired from someone who is infected but has no symptoms. • Shigellosis may be picked up from eating contaminated food, which may look and smell normal. Food may become contaminated by infected food handlers who do not wash their hands properly after using the toilet. They should report sick and avoid handling food if they are ill but they may not always have symptoms. • Vegetables can become contaminated if they are harvested from a field with sewage in it.
    [Show full text]
  • Succession and Persistence of Microbial Communities and Antimicrobial Resistance Genes Associated with International Space Stati
    Singh et al. Microbiome (2018) 6:204 https://doi.org/10.1186/s40168-018-0585-2 RESEARCH Open Access Succession and persistence of microbial communities and antimicrobial resistance genes associated with International Space Station environmental surfaces Nitin Kumar Singh1, Jason M. Wood1, Fathi Karouia2,3 and Kasthuri Venkateswaran1* Abstract Background: The International Space Station (ISS) is an ideal test bed for studying the effects of microbial persistence and succession on a closed system during long space flight. Culture-based analyses, targeted gene-based amplicon sequencing (bacteriome, mycobiome, and resistome), and shotgun metagenomics approaches have previously been performed on ISS environmental sample sets using whole genome amplification (WGA). However, this is the first study reporting on the metagenomes sampled from ISS environmental surfaces without the use of WGA. Metagenome sequences generated from eight defined ISS environmental locations in three consecutive flights were analyzed to assess the succession and persistence of microbial communities, their antimicrobial resistance (AMR) profiles, and virulence properties. Metagenomic sequences were produced from the samples treated with propidium monoazide (PMA) to measure intact microorganisms. Results: The intact microbial communities detected in Flight 1 and Flight 2 samples were significantly more similar to each other than to Flight 3 samples. Among 318 microbial species detected, 46 species constituting 18 genera were common in all flight samples. Risk group or biosafety level 2 microorganisms that persisted among all three flights were Acinetobacter baumannii, Haemophilus influenzae, Klebsiella pneumoniae, Salmonella enterica, Shigella sonnei, Staphylococcus aureus, Yersinia frederiksenii,andAspergillus lentulus.EventhoughRhodotorula and Pantoea dominated the ISS microbiome, Pantoea exhibited succession and persistence. K. pneumoniae persisted in one location (US Node 1) of all three flights and might have spread to six out of the eight locations sampled on Flight 3.
    [Show full text]
  • ABSTRACT DRAKE, STEPHENIE LYNN. the Ecology Vibrio
    ABSTRACT DRAKE, STEPHENIE LYNN. The Ecology Vibrio vulnificus and Vibrio parahaemolyticus from Oyster Harvest Sites in the Gulf of Mexico. (Under the direction of Dr. Lee-Ann Jaykus). The Vibrionaceae are environmentally ubiquitous to estuarine waters. Two species in particular, V. vulnificus and V. parahaemolyticus, are important human pathogens that are transmitted by the consumption of contaminated molluscan shellfish. There is limited information available for the recent risk assessments; accordingly, the purpose of this study was to address some of these data gaps in the V. vulnificus and V. parahaemolyticus risk assessments. The objectives of this study were to (i) quantify the levels of total estuarine bacteria, total Vibrio spp., and specific levels of non-pathogenic and pathogenic V. vulnificus and V. parahaemolyticus over the harvest period; and (ii) determine if length of harvest time affects the levels of V. vulnificus. Oyster and water samples were harvested seasonally from 3 U.S. Gulf Coast sites over 2 years. Environmental parameters were monitored during harvesting. Both surface and bottom water samples (1 L) were taken at the beginning of harvesting and at the end of harvesting. Oyster samples (15 specimens for each time point) were taken at 0, 2.5, 5.0, 7.5, and 10 hrs intervals after being held at ambient temperature during harvesting. Samples were processed for many different bacteria. For enumeration of total V. parahaemolyticus, pathogenic V. parahaemolyticus, and V. vulnificus was done using colony lift hybridization (tlh, tdh+ and/or trh+, and vvhA gene targets, respectively). MPN methods were also used to obtain estimates of pathogenic V.
    [Show full text]
  • Kellie ID Emergencies.Pptx
    4/24/11 ID Alert! recognizing rapidly fatal infections Susan M. Kellie, MD, MPH Professor of Medicine Division of Infectious Diseases, UNMSOM Hospital Epidemiologist UNMHSC and NMVAHCS Fever and…. Rash and altered mental status Rash Muscle pain Lymphadenopathy Hypotension Shortness of breath Recent travel Abdominal pain and diarrhea Case 1. The cross-country trucker A 30 year-old trucker driving from Oklahoma to California is hospitalized in Deming with fever and headache He is treated with broad-spectrum antibiotics, but deteriorates with obtundation, low platelet count, and a centrifugal petechial rash and is transferred to UNMH 1 4/24/11 What is your diagnosis? What is the differential diagnosis of fever and headache with petechial rash? (in the US) Tickborne rickettsioses ◦ RMSF Bacteria ◦ Neisseria meningitidis Key diagnosis in this case: “doxycycline deficiency” Key vector-borne rickettsioses treated with doxycycline: RMSF-case-fatality 5-10% ◦ Fever, nausea, vomiting, myalgia, anorexia and headache ◦ Maculopapular rash progresses to petechial after 2-4 days of fever ◦ Occasionally without rash Human granulocytotropic anaplasmosis (HGA): case-fatality<1% Human monocytotropic ehrlichiosis (HME): case fatality 2-3% 2 4/24/11 Lab clues in rickettsioses The total white blood cell (WBC) count is typicallynormal in patients with RMSF, but increased numbers of immature bands are generally observed. Thrombocytopenia, mild elevations in hepatic transaminases, and hyponatremia might be observed with RMSF whereas leukopenia
    [Show full text]
  • EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
    EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF
    [Show full text]
  • Vol. XXV Issue No. 2 June 2004
    Vol. XXV Issue No. 2 June 2004 Report on the Enhanced Surveillance for Chlamydia West Nile Virus - 2003 Summary and in Women - South Carolina, 1998-2002 the Upcoming Season WAYNE A. DUFFUS, MD, PhD LENA M. BRETOUS, MD, MPH Medical Consultant Medical Consultant Extent of Chlamydia Problem Chlamydia remains a significant health threat among In 2003, South Carolina recorded six human cases of women and adolescents. Most estimates predict that 1 in 20 West Nile Virus (WNV). Surveillance numbers for other WNV sexually active woman of childbearing age or 1 in 10 adoles- positives in 2003 include: 282 birds, 54 equine, 3 mosquito cent girls are infected with chlamydia. In fact, 90% of all pools, and 1 alpaca. See table on page reported cases are in individuals less than 24 years of age. three for human case description. INSIDE THIS ISSUE Unfortunately, 60 – 80% of infected women have no symp- Because of the long stretch of toms, and therefore are not aware of their infection and may warm weather in spring and fall, in- Report on the Enhanced not seek health care. fected mosquitoes have a longer win- Surveillance for Chlamydia is the most commonly reported sexually dow to spread the disease in South Chlamydia in Women - South Carolina, transmitted infection among women in the United States (US). Carolina. The first human WNV case 1998 - 2002 The southeast led the nation in chlamydia prevalence in 2002. in South Carolina during 2003 was also Pg. 1 For example, there were 451.1 cases/100,000 persons diag- the first recorded case in the country nosed in the U.S.
    [Show full text]
  • Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan
    Bioterrorism Diseases Annex Infectious Disease Emergency Response (IDER) Plan Contents I Background IV Activation & Notification II Response Organization V Operational Guidance III Purpose & Objectives VI Resources I. BACKGROUND A bioterrorism event is defined for the purposes of this annex as the deliberate introduction of pathogenic microorganisms or their products (bacteria, viruses, fungi or toxins) into a community. Potential bioterrorism agents are categorized by the Centers for Disease Control and Prevention (CDC) by category. Category A agents (highest priority) include organisms that pose a risk to national security because they can be easily disseminated or transmitted from person-to-person; result in high mortality rates and have the potential for major public health impact; might cause public panic and social disruption; and require special action for public health preparedness. These include: • Anthrax (Bacillus anthracis) • Smallpox (variola major) • Botulism (Clostridium botulinum • Tularemia (Franciscella tularensis) toxin) • Viral Hemorrhagic Fevers (filoviruses, • Plague (Yersinia pestis) arenaviruses) Of second highest priority are category B agents which are organisms that are moderately easy to disseminate; that result in moderate morbidity rates and low mortality rates; and that require enhanced diagnostic capacity and disease surveillance. • Brucellosis (Brucella species)* • Epsilon toxin of Clostridium perfringens • Food safety threats (Salmonella species, Escherichia coli O157:H7, Shigella) • Glanders (Burkholderia
    [Show full text]
  • Fusion of Multiple Heterogeneous Networks for Predicting Circrna
    www.nature.com/scientificreports OPEN Fusion of multiple heterogeneous networks for predicting circRNA- disease associations Received: 22 January 2019 Lei Deng1, Wei Zhang1, Yechuan Shi1 & Yongjun Tang2 Accepted: 18 June 2019 Circular RNAs (circRNAs) are a newly identifed type of non-coding RNA (ncRNA) that plays crucial roles Published: xx xx xxxx in many cellular processes and human diseases, and are potential disease biomarkers and therapeutic targets in human diseases. However, experimentally verifed circRNA-disease associations are very rare. Hence, developing an accurate and efcient method to predict the association between circRNA and disease may be benefcial to disease prevention, diagnosis, and treatment. Here, we propose a computational method named KATZCPDA, which is based on the KATZ method and the integrations among circRNAs, proteins, and diseases to predict circRNA-disease associations. KATZCPDA not only verifes existing circRNA-disease associations but also predicts unknown associations. As demonstrated by leave-one-out and 10-fold cross-validation, KATZCPDA achieves AUC values of 0.959 and 0.958, respectively. The performance of KATZCPDA was substantially higher than those of previously developed network-based methods. To further demonstrate the efectiveness of KATZCPDA, we apply KATZCPDA to predict the associated circRNAs of Colorectal cancer, glioma, breast cancer, and Tuberculosis. The results illustrated that the predicted circRNA-disease associations could rank the top 10 of the experimentally verifed associations. Circular RNA (circRNA) is a class of non-coding RNA recently discovered. Unlike linear RNA, circRNA forms a continuous cycle of covalent closures and is highly represented in the eukaryotic transcriptome. Previous research has found thousands of prototype circRNAs in human, mouse and nematode cells1–4.
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]
  • Whole Day Download the Hansard
    Tuesday Volume 597 30 June 2015 No. 25 HOUSE OF COMMONS OFFICIAL REPORT PARLIAMENTARY DEBATES (HANSARD) Tuesday 30 June 2015 £5·00 © Parliamentary Copyright House of Commons 2015 This publication may be reproduced under the terms of the Open Parliament licence, which is published at www.parliament.uk/site-information/copyright/. 1315 30 JUNE 2015 1316 Robert Flello (Stoke-on-Trent South) (Lab): I draw House of Commons attention to my entry in the register of interests. Many small and medium-sized freight businesses struggle with Tuesday 30 June 2015 the cost of training drivers. Have the Government any plans to look at this afresh with a view to helping people train to become lorry drivers in the UK? The House met at half-past Eleven o’clock Sajid Javid: As the hon. Gentleman will know, it is PRAYERS very important for the Government to listen to all industries about their skills and training needs, including for freight drivers. Of course, the option of apprenticeships [MR SPEAKER in the Chair] is open to that industry, but we must look at other measures too. BUSINESS BEFORE QUESTIONS Mike Wood (Dudley South) (Con): The business rates system is one of the major barriers to competitiveness CONTINGENCIES FUND 2014-15 for small and medium-sized enterprises. What plans do Ordered, Ministers have to reform and alleviate some of that That there be laid before this House an Account of the burden? Contingencies Fund, 2014–15, showing– (1) a Statement of Financial Position; Sajid Javid: My hon. Friend will know that the (2) a Statement of Cash Flows; and Chancellor announced a full review of business rates in (3) Notes to the Account; together with the Certificate and the last Budget.
    [Show full text]
  • Annual Summary of Communicable Disease Reported to MDH, 2003
    MINNESOTA DEPARTMENT OF HEALTH DISEASE CONTROL N EWSLETTER Volume 32, Number 4 (pages 33-52) July/August 2004 Annual Summary of Communicable Diseases Reported to the Minnesota Department of Health, 2003 Introduction Minnesota Government Data Practices do not appear in Table 2 because the Assessment is a core public health Act (Section 13.38). Provisions of the influenza surveillance system is based function. Surveillance for communi- Health Insurance Portability and on reported outbreaks rather than on cable diseases is one type of ongoing Accountability Act (HIPAA) allow for individual cases. assessment activity. Epidemiologic routine communicable disease report- surveillance is the systematic collec- ing without patient authorization. Incidence rates in this report were tion, analysis, and dissemination of calculated using disease-specific health data for the planning, implemen- Since April 1995, MDH has participated numerator data collected by MDH and a tation, and evaluation of public health as one of the Emerging Infections standardized set of denominator data programs. The Minnesota Department Program (EIP) sites funded by the derived from U.S. Census data. of Health (MDH) collects disease Centers for Disease Control and Disease incidence may be categorized surveillance information on certain Prevention (CDC) and, through this as occurring within the seven-county communicable diseases for the program, has implemented active Twin Cities metropolitan area (Twin purposes of determining disease hospital- and laboratory-based surveil- Cities metropolitan area) or outside of it impact, assessing trends in disease lance for several conditions, including (Greater Minnesota). occurrence, characterizing affected selected invasive bacterial diseases populations, prioritizing disease control and food-borne diseases. Anaplasmosis efforts, and evaluating disease preven- Human anaplasmosis (HA) is the new tion strategies.
    [Show full text]